AllomatrineCAS# 641-39-4 |
- Matrine
Catalog No.:BCN5650
CAS No.:519-02-8
- Sophoridine
Catalog No.:BCN4249
CAS No.:6882-68-4
- (+)-Sophoridine
Catalog No.:BCC8360
CAS No.:83148-91-8
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 641-39-4 | SDF | Download SDF |
PubChem ID | 7000681 | Appearance | Powder |
Formula | C15H24N2O | M.Wt | 248.36 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | C1CC2C3CCCN4C3C(CCC4)CN2C(=O)C1 | ||
Standard InChIKey | ZSBXGIUJOOQZMP-KYEXWDHISA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Allomatrine can inhibit proliferation and invasion in vitro of human lung cancer A549 cell line by inducing ROS production,promoting apoptosis, arresting cell cycle, inhibiting ubiquitin proteasome and regulating tumor related gene expression. (+)-Allomatrine and (+)-matrine when given i.c.v. may stimulate the descending dynorphinergic neuron, resulting in the stimulation of KORs in the spinal cord, and this phenomenon in turn produces the antinociception in mice. |
Targets | Bcl-2/Bax | Caspase | Akt | ROS | NF-kB | CDK |
In vitro | Effect and Mechanism of Allomatrine in Proliferation and Invasion in Vitro Inhibition of Human Lung Cancer A549 Cell Line[Reference: WebLink]Chinese Pharmaceutical Journal, 2015 , 50 (13) :1111-6. To investigate the effect and mechanism of Allomatrine in proliferation and invasion in vitro inhibition of human lung cancer A549 cell line. |
In vivo | Implication of the descending dynorphinergic neuron projecting to the spinal cord in the (+)-matrine- and (+)-allomatrine-induced antinociceptive effects.[Pubmed: 15863891]Biol Pharm Bull. 2005 May;28(5):845-8.We previously reported that either (+)-matrine (matridin-15-one) or (+)-Allomatrine (the C-6 epimer of matrine)-induced antinociceptive effect was attenuated by s.c. pretreatment with a kappa-opioid receptor (KOR) antagonist nor-binaltorphimine (nor-BNI), indicating the critical role of KORs in antinociceptive effects induced by these alkaloids.
|
Structure Identification | Org Lett. 2013 Sep 6;15(17):4596-9.Total synthesis of the tetracyclic lupin alkaloid (+)-allomatrine.[Pubmed: 23980915 ](+)-Allomatrine (1) has been synthesized using an imino-aldol reaction and N-acyliminium cyclization as key steps. Strategically, use of the tert-butylsulfinimine derivative of (E)-4-(trimethylsilyl)but-2-enal enabled the staged formation of three C-C bonds, a C-N bond, and the four stereogenic centers within the target. |
Allomatrine Dilution Calculator
Allomatrine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.0264 mL | 20.1321 mL | 40.2641 mL | 80.5283 mL | 100.6603 mL |
5 mM | 0.8053 mL | 4.0264 mL | 8.0528 mL | 16.1057 mL | 20.1321 mL |
10 mM | 0.4026 mL | 2.0132 mL | 4.0264 mL | 8.0528 mL | 10.066 mL |
50 mM | 0.0805 mL | 0.4026 mL | 0.8053 mL | 1.6106 mL | 2.0132 mL |
100 mM | 0.0403 mL | 0.2013 mL | 0.4026 mL | 0.8053 mL | 1.0066 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Alternariol
Catalog No.:BCN7147
CAS No.:641-38-3
- Sennidin A
Catalog No.:BCN6354
CAS No.:641-12-3
- H-Ala(3-pyridyl)-OH.HCl
Catalog No.:BCC3321
CAS No.:64090-98-8
- Cannabispirol
Catalog No.:BCN4609
CAS No.:64052-90-0
- GANT 58
Catalog No.:BCC1587
CAS No.:64048-12-0
- Ro 04-5595 hydrochloride
Catalog No.:BCC7234
CAS No.:64047-73-0
- Z-D-Pro-OH
Catalog No.:BCC2752
CAS No.:6404-31-5
- Boc-ε-Acp-OH
Catalog No.:BCC3205
CAS No.:6404-29-1
- Boc-Nle-OH
Catalog No.:BCC3296
CAS No.:6404-28-0
- Boc-Lys(Ac)-OH
Catalog No.:BCC3411
CAS No.:6404-26-8
- Torachrysone 8-O-glucoside
Catalog No.:BCN4181
CAS No.:64032-49-1
- 4(15)-Oppositene-1,7-diol
Catalog No.:BCN4180
CAS No.:640289-58-3
- 5-hydroxy-canthin-6-one
Catalog No.:BCN7910
CAS No.:64118-73-6
- Di-O-methylcrenatin
Catalog No.:BCN4608
CAS No.:64121-98-8
- Longistylin C
Catalog No.:BCN4182
CAS No.:64125-60-6
- Sedanolide
Catalog No.:BCN8338
CAS No.:6415-59-4
- Nilotinib(AMN-107)
Catalog No.:BCC3643
CAS No.:641571-10-0
- Echinoynethiophene A
Catalog No.:BCN4183
CAS No.:64165-98-6
- 5-Acetyl-2-(1-hydroxy-1-methylethyl)benzofuran
Catalog No.:BCN7488
CAS No.:64165-99-7
- 30-Oxolupeol
Catalog No.:BCN6673
CAS No.:64181-07-3
- trans-2,3-Dihydro-3-hydroxyeuparin
Catalog No.:BCN6922
CAS No.:64185-57-5
- Z-Hyp-Ome
Catalog No.:BCC3258
CAS No.:64187-48-0
- Zanthobungeanine
Catalog No.:BCN6685
CAS No.:64190-94-9
- Senaetnine
Catalog No.:BCN2127
CAS No.:64191-69-1
Implication of the descending dynorphinergic neuron projecting to the spinal cord in the (+)-matrine- and (+)-allomatrine-induced antinociceptive effects.[Pubmed:15863891]
Biol Pharm Bull. 2005 May;28(5):845-8.
We previously reported that either (+)-matrine (matridin-15-one) or (+)-Allomatrine (the C-6 epimer of matrine)-induced antinociceptive effect was attenuated by s.c. pretreatment with a kappa-opioid receptor (KOR) antagonist nor-binaltorphimine (nor-BNI), indicating the critical role of KORs in antinociceptive effects induced by these alkaloids. In the present study, we found that i.c.v. administration of either (+)-matrine- or (+)-Allomatrine induced antinociceptive effects in the mouse tail-flick and warm-plate test, whereas these alkaloids when given spinally failed to induce antinociception. In the guanosine-5'-O-(3-[(35)S]thio)trisphosphate ([(35)S]GTPgammaS) binding assay, we demonstrated that neither (+)-matrine nor (+)-Allomatrine produced the stimulation of [(35)S]GTPgammaS binding in the membranes of the spinal cord, indicating that (+)-matrine- and (+)-Allomatrine-induced supraspinal antinociceptive actions was not due to a direct stimulation of KORs by these alkaloids. Therefore, we next investigated the involvement of dynorphin A (1-17) release at the spinal or supraspinal site in (+)-matrine- or (+)-Allomatrine-induced antinociception. The i.c.v. pretreatment with an antiserum against dynorphin A (1-17) could not affect the antinociceptive effect induced by s.c. treatment of (+)-matrine. In contrast, the s.c.-administered (+)-matrine- and (+)-Allomatrine-induced antinociceptive effect was significantly attenuated by i.t. pretreatment of an antiserum against dynorphin A (1-17). The present data suggest that either (+)-matrine or (+)-Allomatrine when given i.c.v. may stimulate the descending dynorphinergic neuron, resulting in the stimulation of KORs in the spinal cord, and this phenomenon in turn produces the antinociception in mice.
Total synthesis of the tetracyclic lupin alkaloid (+)-allomatrine.[Pubmed:23980915]
Org Lett. 2013 Sep 6;15(17):4596-9.
(+)-Allomatrine (1) has been synthesized using an imino-aldol reaction and N-acyliminium cyclization as key steps. Strategically, use of the tert-butylsulfinimine derivative of (E)-4-(trimethylsilyl)but-2-enal enabled the staged formation of three C-C bonds, a C-N bond, and the four stereogenic centers within the target.